ASSET | DATE | % RETURN |
---|---|---|
NewAmsterdam Pharma Company NV Warrant (NAMSW) | 3/21/2022 - 3/21/2025 | 7,622.22% |
Azitra (AZTR) | 3/21/2022 - 3/21/2025 | 5,794.64% |
ADMA Biologics (ADMA) | 3/21/2022 - 3/21/2025 | 1,078.57% |
Soleno Therapeutics (SLNO) | 3/21/2022 - 3/21/2025 | 954.77% |
Viking Therapeutics (VKTX) | 3/21/2022 - 3/21/2025 | 746.49% |
Nuvalent (NUVL) | 3/21/2022 - 3/21/2025 | 534.34% |
Summit Therapeutics (SMMT) | 3/21/2022 - 3/21/2025 | 528.98% |
Belite Bio Inc ADR (BLTE) | 3/21/2022 - 3/21/2025 | 438.24% |
LENZ Therapeutics (LENZ) | 3/21/2022 - 3/21/2025 | 384.32% |
Biohaven Pharmaceutical (BHVN) | 3/21/2022 - 3/21/2025 | 375.67% |
Ardelyx (ARDX) | 3/21/2022 - 3/21/2025 | 375% |
Bright Minds Biosciences (DRUG) | 3/21/2022 - 3/21/2025 | 375% |
Rhythm Pharmaceuticals (RYTM) | 3/21/2022 - 3/21/2025 | 367.57% |
Arcellx (ACLX) | 3/21/2022 - 3/21/2025 | 351.37% |
TG Therapeutics (TGTX) | 3/21/2022 - 3/21/2025 | 330.76% |
MoonLake Immunotherapeutics (MLTX) | 3/21/2022 - 3/21/2025 | 303.22% |
Natera (NTRA) | 3/21/2022 - 3/21/2025 | 278.06% |
Madrigal Pharmaceuticals (MDGL) | 3/21/2022 - 3/21/2025 | 247.85% |
Insmed (INSM) | 3/21/2022 - 3/21/2025 | 233.14% |
Immunovant (IMVT) | 3/21/2022 - 3/21/2025 | 219.35% |
Catalyst Pharmaceuticals (CPRX) | 3/21/2022 - 3/21/2025 | 218.4% |
Alvotech Warrant (ALVOW) | 3/21/2022 - 3/21/2025 | 216.84% |
BridgeBio Pharma (BBIO) | 3/21/2022 - 3/21/2025 | 212.96% |
Akero Therapeutics (AKRO) | 3/21/2022 - 3/21/2025 | 210.36% |
Silverback Therapeutics (SPRY) | 3/21/2022 - 3/21/2025 | 198.19% |